JP2009534393A5 - - Google Patents

Download PDF

Info

Publication number
JP2009534393A5
JP2009534393A5 JP2009506622A JP2009506622A JP2009534393A5 JP 2009534393 A5 JP2009534393 A5 JP 2009534393A5 JP 2009506622 A JP2009506622 A JP 2009506622A JP 2009506622 A JP2009506622 A JP 2009506622A JP 2009534393 A5 JP2009534393 A5 JP 2009534393A5
Authority
JP
Japan
Prior art keywords
organic radical
morphinone
borohydride
item
following structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009506622A
Other languages
English (en)
Japanese (ja)
Other versions
JP5586223B2 (ja
JP2009534393A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/009761 external-priority patent/WO2007124114A2/en
Publication of JP2009534393A publication Critical patent/JP2009534393A/ja
Publication of JP2009534393A5 publication Critical patent/JP2009534393A5/ja
Application granted granted Critical
Publication of JP5586223B2 publication Critical patent/JP5586223B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009506622A 2006-04-21 2007-04-19 モルヒノンの立体選択的還元 Active JP5586223B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74533606P 2006-04-21 2006-04-21
US60/745,336 2006-04-21
PCT/US2007/009761 WO2007124114A2 (en) 2006-04-21 2007-04-19 Stereoselective reduction of a morphinone

Publications (3)

Publication Number Publication Date
JP2009534393A JP2009534393A (ja) 2009-09-24
JP2009534393A5 true JP2009534393A5 (cg-RX-API-DMAC7.html) 2010-06-03
JP5586223B2 JP5586223B2 (ja) 2014-09-10

Family

ID=38625648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009506622A Active JP5586223B2 (ja) 2006-04-21 2007-04-19 モルヒノンの立体選択的還元

Country Status (13)

Country Link
US (2) US8183376B2 (cg-RX-API-DMAC7.html)
EP (1) EP2010539B1 (cg-RX-API-DMAC7.html)
JP (1) JP5586223B2 (cg-RX-API-DMAC7.html)
KR (1) KR101421747B1 (cg-RX-API-DMAC7.html)
CN (1) CN101466381B (cg-RX-API-DMAC7.html)
AU (1) AU2007240680B2 (cg-RX-API-DMAC7.html)
CA (1) CA2646313C (cg-RX-API-DMAC7.html)
ES (1) ES2629766T3 (cg-RX-API-DMAC7.html)
IL (1) IL194735A (cg-RX-API-DMAC7.html)
MX (1) MX2008013594A (cg-RX-API-DMAC7.html)
NZ (1) NZ572252A (cg-RX-API-DMAC7.html)
WO (1) WO2007124114A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200809258B (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056500B2 (en) 2001-10-18 2006-06-06 Nektar Therapeutics Al, Corporation Polymer conjugates of opioid antagonists
CN1925875A (zh) * 2003-12-16 2007-03-07 尼克塔治疗亚拉巴马公司 化学改性的小分子
US20060182692A1 (en) 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
CN102014907A (zh) * 2008-05-07 2011-04-13 尼克塔治疗公司 外周作用阿片拮抗剂的口服给药
NZ589963A (en) * 2008-06-17 2011-08-26 Mallinckrodt Inc Processes for the preparation of 6- beta-hydroxy morphinan compounds
MX347741B (es) * 2008-09-16 2017-05-10 Nektar Therapeutics Opioides pegilados con bajo potencial de abuso.
AU2010239059B2 (en) 2009-04-24 2016-06-09 Brock University Processes for the preparation of morphinane and morphinone compounds
CA2936749C (en) 2010-06-11 2019-07-09 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
TWI471289B (zh) 2010-06-11 2015-02-01 Rhodes Technologies 使三級胺進行n-脫烷反應之方法
SI2621496T2 (sl) 2010-09-30 2019-04-30 Astrazeneca Ab Kristalinični konjugat naloksol-PEG
CN103289075B (zh) * 2012-02-22 2016-01-20 天津键凯科技有限公司 聚乙二醇与纳洛酮的结合物及其药物组合物和应用
CA2886276A1 (en) 2012-10-30 2014-05-08 Nektar Therapeutics Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof
AU2015253417B2 (en) 2014-04-28 2020-02-20 Dimerx, Inc. Pharmaceutically active dimers linked through phenolic hydroxyl groups
WO2016028636A1 (en) * 2014-08-16 2016-02-25 Memorial Sloan Kettering Cancer Center Helical polycarbodiimide polymers and associated imaging, diagnostic, and therapeutic methods
CN107033155B (zh) * 2016-02-04 2019-04-26 国药集团国瑞药业有限公司 一种吗啡酮类化合物的立体选择性还原方法
US11077103B2 (en) * 2016-11-23 2021-08-03 Aurobindo Pharma Ltd. Naloxegol oxalate and solid dispersion thereof
CN110305142B (zh) * 2019-07-12 2021-11-16 宜昌人福药业有限责任公司 一种6β-羟基吗啡衍生物的立体选择性合成方法
CN110330500B (zh) * 2019-07-12 2021-11-23 宜昌人福药业有限责任公司 一种6β-羟基-7,8-二氢-吗啡衍生物的立体选择性合成方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2654756A (en) * 1949-10-20 1953-10-06 Mallinckrodt Chemical Works Process of preparing codeinone, dihydrocodeinone, and dihydromorphinone
US2628962A (en) 1949-10-20 1953-02-17 Mallinckrodt Chemical Works Method for preparing dihydrocodeinone, dihydromorphinone, and codeinone
US2715626A (en) 1950-07-05 1955-08-16 Merck & Co Inc Process of preparing dihydrocodeinone
US2649454A (en) 1951-08-20 1953-08-18 Univ California Method for preparing dihydromorphinone, dihydrocodeinone, and dihydropseudocodeinone
US2654746A (en) 1952-02-13 1953-10-06 Lilly Co Eli 1-dimethylamino-4-chloro-4-phenylbutane salt of penicillin
US2806033A (en) 1955-08-03 1957-09-10 Lewenstein Morphine derivative
US3254088A (en) 1961-03-14 1966-05-31 Lewenstein Morphine derivative
US3332950A (en) 1963-03-23 1967-07-25 Endo Lab 14-hydroxydihydronormorphinone derivatives
IL26896A (en) * 1966-01-19 1970-11-30 Endo Lab 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
DE2538075A1 (de) * 1975-08-27 1977-03-17 Boehringer Sohn Ingelheim N-tetrahydrofurfuryl-noroxymorphone, deren saeureadditionssalze, diese enthaltende arzneimittel sowie verfahren zu ihrer herstellung
US4089855A (en) * 1976-04-23 1978-05-16 Cornell Research Foundation, Inc. Process for the stereoselective reduction of 6- and 8-keto morphine and morphinan derivatives with formamidinesulfinic acid and compounds obtained thereby
GB1593191A (en) * 1977-03-23 1981-07-15 Reckitt & Colmann Prod Ltd Derivatives of morphine
US4451470A (en) * 1982-07-06 1984-05-29 E. I. Du Pont De Nemours And Company Analgesic, antagonist, and/or anorectic 14-fluoromorphinans
US5208338A (en) 1991-06-14 1993-05-04 The United States Of America As Represented By The Department Of Health & Human Services. Radiolabeled N-substituted-6-iodo-3,14-dihydroxy-4,5α-epoxymorphinans
DE4132159A1 (de) * 1991-09-27 1993-04-01 Boehringer Ingelheim Kg 14-hydroxy-n-(2-methoxyethyl)-7,8-dihydromorphin und -norisomorphin, verfahren zu deren herstellung und deren verwendung als arzneimittel
JP2525552B2 (ja) * 1992-01-23 1996-08-21 東レ株式会社 モルヒナン誘導体および医薬用途
US5428159A (en) 1994-04-08 1995-06-27 Ciba-Geigy Corporation Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine
DE69507697T2 (de) * 1994-05-31 1999-06-10 Mallinckrodt Chemical, Inc., Chesterfield, Mo. Verfahren zur herstellung von nalbuphin das wenig des 6-beta-epimers enthält
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US7056500B2 (en) 2001-10-18 2006-06-06 Nektar Therapeutics Al, Corporation Polymer conjugates of opioid antagonists
CN1925875A (zh) 2003-12-16 2007-03-07 尼克塔治疗亚拉巴马公司 化学改性的小分子

Similar Documents

Publication Publication Date Title
JP2020525426A5 (cg-RX-API-DMAC7.html)
US9988417B2 (en) Process for the preparation of estetrol
JP2013520495A5 (cg-RX-API-DMAC7.html)
JP2004517980A5 (cg-RX-API-DMAC7.html)
JP2009138000A5 (cg-RX-API-DMAC7.html)
JP2012062467A5 (cg-RX-API-DMAC7.html)
WO2009115967A3 (en) Method for the synthesis of hollow spheres
JP2010536889A5 (cg-RX-API-DMAC7.html)
JP2009035515A (ja) シルセスキオキサンを含有する組成物及びシルセスキオキサン含有ヒドロキシアルキルセルロース樹脂組成物
JP2017505801A5 (cg-RX-API-DMAC7.html)
CA2646313A1 (en) Stereoselective reduction of a morphinone
JPWO2023058781A5 (cg-RX-API-DMAC7.html)
JP2009536939A5 (cg-RX-API-DMAC7.html)
US9156696B2 (en) Process and method for the efficient preparation of fullerynes
US10676636B2 (en) Brush composition, and method of producing structure containing phase-separated structure
JP2019515906A5 (cg-RX-API-DMAC7.html)
JP5641519B2 (ja) ステレオコンプレックス体及びその製造方法
JP2010539263A5 (cg-RX-API-DMAC7.html)
TW201024327A (en) Acrylic copolymers with high heat-resistance and preparation thereof
JP2007070607A5 (cg-RX-API-DMAC7.html)
JPWO2022215652A5 (cg-RX-API-DMAC7.html)
JP2007529433A5 (cg-RX-API-DMAC7.html)
JP2008512421A5 (cg-RX-API-DMAC7.html)
JP2008248147A (ja) 新規ポリマーおよびアニオン重合用カップリング剤
JP2007210969A5 (cg-RX-API-DMAC7.html)